Skip to content

Clinical trials

Phase 2/3 Neoplasm Metastasis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2/3 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20071
20091
20121
20141
20151
20171
20181
20192
20212
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Completed6
Recruiting5
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Bellus Health Inc. - a GSK company1
BioNTech SE1
Bristol-Myers Squibb1
Celgene Corporation1
Clovis Oncology, Inc.1
Eikon Therapeutics1
Exelixis1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis21
Recurrence5
Neoplasms4
Delirium2
Fatigue2
Head and Neck Neoplasms2
Melanoma2
Pancreatic Neoplasms2
Prostatic Neoplasms2
Adenoma, Islet Cell1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.